Legendary Sports Icons, Nadia Comaneci and Mark Spitz, Support Your Personal Best Public Education Campaign
Spitz and Comaneci to Share Tips on Achieving Your Personal Best and Discuss Why They Talked To Their Physicians About BOTOX(R) Cosmetic (Botulinum Toxin Type A) Treatment
NEW YORK, July 15, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Five-time gold medalist, Nadia Comaneci, and nine-time gold medalist, Mark Spitz, today joined Allergan, Inc. (NYSE: AGN), the maker of BOTOX(R) Cosmetic (Botulinum Toxin Type A), to launch a new consumer education campaign -- Your Personal Best. As part of the campaign, Comaneci and Spitz will share tips on how they remain at the top of their game in an effort to inspire men and women to achieve their own personal best -- be it through diet, exercise or by improving their personal skin care routine.
According to a recent national survey (n = 2,403), four in five people define their personal best as a combination of feeling their best, looking their best and fulfilling their responsibilities.(1) Recognizing this, long- time friends, Comaneci (46) and Spitz (58) will travel the nation offering tips and insights on how women and men can define their own personal gold standard and achieve their goals.
According to acclaimed dermatologist and psychiatrist, Dr. Amy Wechsler, the Your Personal Best mission of encouraging people to define their own personal best and focus on total wellness is often a key factor to personal satisfaction. "I always tell my patients that their health and personal state of mind are closely connected. Simply put, improving your state of mind can be achieved by exercising, making healthy food choices and taking care of your skin. As a dermatologist, I recommend a personalized skin care regimen to help my patients achieve the results they're looking for. By helping them improve their skin, I am putting them a step closer to achieving the ultimate mind- body connection."
This is true for Comaneci who describes her personal best as taking care of her inner and outer self. "As a mother of an active two-year old boy, I am constantly on the go and trying to find time to take care of myself," said Comaneci, who today runs a gymnastics school with husband and fellow gold- medalist gymnast, Bart Conner. "About five years ago, I realized that while I exercised and ate right most of my life, there was nothing I could do on my own that would get rid of those two stubborn frown lines stamped on my forehead. They looked like an '11' and made me upset with the way I looked, and that's when I decided to talk to my physician about BOTOX(R) Cosmetic treatment. I attained a perfect '10' at age 14, and I'm working hard to stay close to that in all that I do."
How the "11" Makes People Feel
Also according to the survey, approximately 60 percent of women and men agree that their "11" presents negative connotations.(2) Dr. Wechsler attributes the negative emotions stirred by the glabellar lines, commonly referred to as the "11", as a significant contributor to why millions of women and men talk to their physicians about and have treatment with BOTOX(R) Cosmetic each year.
Already common among women, this trend is growing rapidly among men. According to the American Society for Aesthetic Plastic Surgery, in 2007, there was a 20 percent increase in men opting for non-surgical aesthetic procedures, including BOTOX(R) Cosmetic.(3) BOTOX(R) Cosmetic was also the most popular non-surgical aesthetic procedure among men.(4)
Mark Spitz, who holds the world record for the greatest number of gold medals achieved in a single Olympic game and was named one of the sexiest men over 50 by MSN.com, decided to talk to his physician about getting treated with BOTOX(R) Cosmetic for the first time. "As a financial advisor and motivational speaker, my facial expression is a very important part of my message," said Spitz. "When I am serious, my '11' makes me look angry and unapproachable rather than congenial. I knew I had to do something about it, but for a long time, I just didn't know what my options were. Then I heard about BOTOX(R) Cosmetic and spoke to my wife about it. She encouraged me to see a great doctor who answered all my questions."
Spitz is not alone. The survey also found that men are four times more likely to consider aesthetic treatments if their significant other recommends them.(5,6)
"Today, more and more women bring their husbands into my office for a BOTOX(R) Cosmetic treatment to lose their '11,'" said Dr. Wechsler. "Men are now learning what women who are treated with BOTOX(R) Cosmetic have known for a long time -- it's not about looking younger, but about achieving a natural look."
Sharing Tips to Achieve Your Personal Best
Comaneci and Spitz will participate in local Your Personal Best events where they will share their personal stories including their experiences with BOTOX(R) Cosmetic. Attendees also will have the opportunity to ask a physician expert questions about BOTOX(R) Cosmetic and will receive simple steps to help them achieve their personal best, including ways to:
-- Reduce Stress - Approximately three-quarters (77%) of Americans experienced physical symptoms of stress (fatigue, upset stomach, dizziness)(7)
-- Be Sun Smart - While 58 percent of people say they are concerned about skin cancer, 40 percent of Americans never use sunscreen and only 11 percent use an SPF15 or higher daily(8)
-- Get Active - 39.5 percent of U.S. adults are physically inactive(9)
-- Catch Some Zs - Approximately 7 in 10 U.S. adults (71%) are getting less than the recommended eight hours of sleep a night on weekdays(10)
The Your Personal Best campaign Web site, www.YPBevents.com, will provide information on registration for the events, tips for achieving your best along with questions to ask your physician about BOTOX(R) Cosmetic.
Important BOTOX(R) Cosmetic (Botulinum Toxin Type A) Information
BOTOX(R) Cosmetic is indicated for the temporary improvement in the appearance of moderate to severe frown lines between the brows in people 18 to 65 years of age.
Important BOTOX(R) Cosmetic (Botulinum Toxin Type A) Safety Information
Serious heart problems and serious allergic reactions have been reported rarely. If you think you are having an allergic reaction or other reactions, such as difficulty swallowing, speaking or breathing, call your doctor immediately. The most common side effects following injection are temporary eyelid droop and nausea. Patients with certain neuromuscular disorders such as ALS, myasthenia gravis or Lambert-Eaton syndrome may be at increased risk of serious side effects.
For full prescribing information, please visit http://www.botoxcosmetic.com/resources/pi.aspx
Your Personal Best Survey Methodology
TSC, a division of Yankelovich, Inc., conducted a phone omnibus of 2,403 men and women ages 30 to 64 in the United States. A national probability sample was used, based on random-digit dialing and including both listed and unlisted phone numbers. Data were weighted by age, sex, geographic region and race to ensure reliable and accurate representation of the total population. The margin of error for this study is plus or minus 2.8% among men and plus or minus 2.8% among women. Statistical differences between groups are set at the 95% confidence interval. The survey was funded by Allergan, Inc.
About Allergan, Inc.
With more than 55 years of experience providing high-quality, science- based products, Allergan, Inc., with headquarters in Irvine, California, discovers, develops and commercializes products in the ophthalmology, neurosciences, medical dermatology, medical aesthetics, obesity intervention and other specialty markets that deliver value to its customers, satisfy unmet medical needs, and improve patients' lives.
About Allergan Medical
Allergan Medical, a division of Allergan, Inc., offers the most comprehensive, science-based, aesthetic product offerings under its Total Facial Rejuvenation portfolio, including BOTOX(R) Cosmetic; hyaluronic acid and collagen-based dermal fillers; and physician-dispensed skin care products. Allergan Medical also offers the industry's widest range of breast implant options for reconstructive and aesthetic breast surgery, and leading minimally invasive devices for obesity intervention treatment.
This press release contains "forward-looking statements", including statements by Ms. Comaneci, Mr. Spitz and Dr. Wechsler and statements regarding research and development outcomes, efficacy, adverse events, market and product potential and other statements regarding BOTOX(R) Cosmetic.
These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Allergan's expectations and projections. Risks and uncertainties include, among other things, general industry and market conditions; technological advances and patents attained by competitors; challenges inherent in the research and development and regulatory processes; challenges related to product marketing, such as the unpredictability of market acceptance for new products and/or the acceptance of new indications for such products; inconsistency of treatment results among patients and the potential for product failures; unknown risks associated with the investigational devices that are the subject of clinical trials; potential difficulties in manufacturing new products; general economic conditions; and governmental laws and regulations affecting domestic and foreign operations. Allergan expressly disclaims any intent or obligation to update these forward- looking statements except as required to do so by law.
Additional information concerning these and other risk factors can be found in press releases issued by Allergan, as well as Allergan's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in Allergan's 2007 Form 10-K and Allergan's Form 10-Q for the quarter ended March 31, 2008. Copies of Allergan's press releases and additional information about Allergan is available on the World Wide Web at www.allergan.com or you can contact the Allergan Investor Relations Department by calling 1-714-246-4636.
(C) 2008 Allergan, Inc. Irvine, CA 92612. (R) mark owned by Allergan, Inc.
(1) TSC, a division of Yankelovich. "BOTOX(R) Cosmetic Your Personal Best." June 2008. Page 1.
(2) TSC, a division of Yankelovich. "BOTOX(R) Cosmetic Your Personal Best." June 2008. Page 3.
(3) American Society for Aesthetic Plastic Surgery. 2007 Cosmetic Surgery Statistics. Available at: http://www.surgery.org/press/statistics.php Retrieved May 29, 2008.
(4) American Society for Aesthetic Plastic Surgery. 2007 Cosmetic Surgery Statistics. Available at: http://www.surgery.org/press/statistics.php Retrieved May 29, 2008.
(5) TSC, a division of Yankelovich. "BOTOX(R) Cosmetic Your Personal Best." June 2008. Page 7.
(6) TSC, a division of Yankelovich. "BOTOX(R) Cosmetic Your Personal Best." June 2008. Page 5
(7) American Psychological Association. Stress a Major Health Problem in the U.S., Warns APA. October 24, 2007. Available at: http://www.apa.org/releases/stressproblem.html.Retrieved June 2. 2008.
(8) Skin Cancer Foundation. Survey: Tanned Skin Losing its Appeal. May 28, 2007. Available at http://www.skincancer.org/content/view/252/70. Retrieved June 2, 2008.
(9) National Center for Health Statistics. Health, United States, 2007 with Chartbook on Trends in the Health of Americans. Hyattsville, MD: 2007. Page 286. Available at: http://www.cdc.gov/nchs/data/hus/hus07.pdf
(10) National Commission on Sleep Disorders Research. (1992) Wake Up America: A National Sleep Alert. Report of the National Commission on Sleep Disorders Research. Washington, DC.
SOURCE Allergan, Inc.
Copyright (C) 2008 PR Newswire. All rights reserved
News Provided by COMTEX